Cargando…

Allopurinol Is an Independent Determinant of Improved Arterial Stiffness in Chronic Kidney Disease: A Cross-Sectional Study

BACKGROUND: Arterial stiffness is increased in patients with CKD and is a powerful predictor of cardiovascular morbidity and mortality. Use of the xanthine oxidase inhibitor allopurinol has been shown to improve endothelial function, reduce left ventricular hypertrophy and possibly improve cardiovas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Khai P., Stringer, Stephanie J., Jesky, Mark D., Yadav, Punit, Athwal, Rajbir, Dutton, Mary, Ferro, Charles J., Cockwell, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954864/ https://www.ncbi.nlm.nih.gov/pubmed/24632580 http://dx.doi.org/10.1371/journal.pone.0091961

Ejemplares similares

Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study
por: Jesky, Mark D., et al.
Publicado: (2016)

The natural history of, and risk factors for, progressive Chronic Kidney Disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol
por: Stringer, Stephanie, et al.
Publicado: (2013)

Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease
por: Fenton, Anthony, et al.
Publicado: (2018)

Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRU
por: Brothwell, Shona, et al.
Publicado: (2013)

Effects of Allopurinol on Arterial Stiffness: A Meta-Analysis of Randomized Controlled Trials
por: Deng, Gang, et al.
Publicado: (2016)

Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease
por: Fenton, Anthony, et al.
Publicado: (2017)

The impact of chronic kidney disease and cardiovascular comorbidity on mortality in a multiethnic population: a retrospective cohort study
por: Jesky, Mark, et al.
Publicado: (2013)

Incidence and impact on outcomes of acute kidney injury after a stroke: a systematic review and meta-analysis
por: Arnold, Julia, et al.
Publicado: (2018)

Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients
por: Genovese, Federica, et al.
Publicado: (2020)

Urinary endotrophin predicts disease progression in patients with chronic kidney disease
por: Rasmussen, Daniel Guldager Kring, et al.
Publicado: (2017)

A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease
por: Holm Nielsen, Signe, et al.
Publicado: (2018)

Recent Advances in the Pathogenesis and Management of Cast Nephropathy (Myeloma Kidney)
por: Stringer, Stephanie, et al.
Publicado: (2011)

Allopurinol for prevention of progression of kidney disease with hyperuricemia
por: Pai, B. H. Santhosh, et al.
Publicado: (2013)

Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol
por: Kyte, Derek, et al.
Publicado: (2018)

Determinants of Arterial Stiffness in Chronic Kidney Disease Stage 3
por: McIntyre, Natasha J., et al.
Publicado: (2013)

A Randomized Controlled Trial of Allopurinol in Patients With Peripheral Arterial Disease
por: Robertson, Alan J., et al.
Publicado: (2016)

Glycated Albumin is Independently Associated With Arterial Stiffness in Non-Diabetic Chronic Kidney Disease Patients
por: Choi, Hoon Young, et al.
Publicado: (2016)

Clinical Significance of Pre-Transplant Arterial Stiffness and the Impact of Kidney Transplantation on Arterial Stiffness
por: Kim, Hyun Seon, et al.
Publicado: (2015)

Allopurinol induced erythroderma
por: Sharma, Geeta, et al.
Publicado: (2013)

Allopurinol: Sorrow to the marrow
por: Raaju, UR, et al.
Publicado: (2020)

Allopurinol hypersensitivity syndrome
por: Yaseen, Wid, et al.
Publicado: (2023)

Cytomegalovirus Seropositivity Is Associated with Increased Arterial Stiffness in Patients with Chronic Kidney Disease
por: Wall, Nadezhda A., et al.
Publicado: (2013)

Allopurinol attenuates acute kidney injury following Bothrops jararaca envenomation
por: Gois, Pedro Henrique França, et al.
Publicado: (2017)

The Functional Polymorphism of DDAH2 rs9267551 Is an Independent Determinant of Arterial Stiffness
por: Averta, Carolina, et al.
Publicado: (2022)

Arterial Stiffness, Kidney Function, and Chronic Kidney Disease Progression
por: Townsend, Raymond R., et al.
Publicado: (2013)

Using patient-reported outcome measures (PROMs) to promote quality of care in the management of patients with established kidney disease requiring treatment with haemodialysis in the UK (PROM-HD): a qualitative study protocol
por: Anderson, Nicola Elzabeth, et al.
Publicado: (2018)

Allopurinol-induced DRESS syndrome
por: Yaylacı, Selcuk, et al.
Publicado: (2012)

Transient hypofibrinogenemia due to allopurinol
por: Yin, ZhiQiang, et al.
Publicado: (2014)

Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study
por: Rey, Amayelle, et al.
Publicado: (2019)

Superior effect of allopurinol compared to febuxostat on the retardation of chronic kidney disease progression
por: Park, Seokwoo, et al.
Publicado: (2022)

Sleep disorder, an independent risk associated with arterial stiffness in menopause
por: Zhou, Yang, et al.
Publicado: (2017)

Arterial Stiffness Can Be Modulated by Pressure‐Independent Mechanisms in Hypertension
por: Faconti, Luca, et al.
Publicado: (2019)

Allopurinol-Induced Toxic Epidermal Necrolysis
por: Buenrostro-Rubio, Ignacio, et al.
Publicado: (2019)

Risk Factors for Metabolic Syndrome Independently Predict Arterial Stiffness and Endothelial Dysfunction in Patients With Chronic Kidney Disease and Minimal Comorbidity
por: Lilitkarntakul, Pajaree, et al.
Publicado: (2012)

Determinants of arterial stiffness in COPD
por: Bhatt, Surya P, et al.
Publicado: (2014)

Clinical Potential of Allopurinol in the Treatment of Bipolar Disorder
por: Bishnoi, Ram J.
Publicado: (2014)

Reversal of Arterial Stiffness and Maladaptative Arterial Remodeling After Kidney Transplantation
por: Karras, Alexandre, et al.
Publicado: (2017)

Using patient-reported outcome measures during the management of patients with end-stage kidney disease requiring treatment with haemodialysis (PROM-HD): a qualitative study
por: Anderson, Nicola Elzabeth, et al.
Publicado: (2021)

HJURP antagonizes CENP-A mislocalization driven by the H3.3 chaperones HIRA and DAXX
por: Nye, Jonathan, et al.
Publicado: (2018)

A Decreased Level of Serum Soluble Klotho Is an Independent Biomarker Associated with Arterial Stiffness in Patients with Chronic Kidney Disease
por: Kitagawa, Masashi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jgtd8nfgv8143sn11saakusqvq